Wells Fargo heads into its July 14 Q2 earnings report with options hedging at its lightest in months, peers lifting alongside it, and short sellers offering essentially no signal either way.
The options picture has continued to ease since the previous article noted the unwind. The put/call ratio has settled further to 1.25, now running nearly 1.2 standard deviations below its 20-day average of 1.33. That places current hedging demand closer to its 52-week low of 0.43 than to the defensive highs above 1.50 seen in early June. Investors who were carrying downside protection through the first half of June have largely let it run off. The lending market reinforces the same message: borrow costs have fallen to 0.28%, down 26% on the week, with shares available in enormous surplus — the borrow market is effectively unconstrained.
The analyst backdrop, consistent with what was reported earlier this week, remains constructive in direction if not unanimous in conviction. BofA holds a Buy with a $102 target after raising it from $95 on July 7. JPMorgan lifted its Neutral target to $93.50 from $86.50. The consensus mean target of $98.34 implies roughly 13% upside from the current price of $87.16. The bull case rests on book value growth of 9% year-over-year, core ROE at 13.3%, and NII near $12.3 billion. Bears counter with a CET1 ratio that has slipped to 10.6%, a quarter-on-quarter drop in noninterest income to $8.96 billion, and NIM compressing to 2.60%. Both sides have data to work with; neither has changed the rating landscape materially.
Among close peers, the week's price action offers useful context. BAC gained 1.5% and JPM added 0.4%, both trading in line with WFC's 1.9% weekly advance. Regional names diverged more sharply: MTB and KEY both pulled back on the week, while TFC led the group with a 0.9% gain. WFC's move is therefore neither an outlier nor a laggard — it has tracked the large-cap money-center cohort closely, suggesting no stock-specific positioning pressure ahead of the print.
The Q2 report on July 14 is therefore less a test of whether the recovery narrative holds and more a test of whether NIM stabilisation and fee income trends can justify a stock that has re-rated 6% higher over the past month into a consensus that remains, at best, cautiously constructive.
See the live data behind this article on ORTEX.
Open WFC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
